Compare NTRA & EQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRA | EQT |
|---|---|---|
| Founded | 2003 | 1925 |
| Country | United States | United States |
| Employees | N/A | 1873 |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2B | 34.2B |
| IPO Year | 2015 | 1994 |
| Metric | NTRA | EQT |
|---|---|---|
| Price | $197.88 | $56.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $259.07 | $69.15 |
| AVG Volume (30 Days) | 1.4M | ★ 6.8M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | 0.65 | ★ 635.56 |
| EPS | N/A | ★ 2.36 |
| Revenue | $210,939,000.00 | ★ $8,644,211,000.00 |
| Revenue This Year | $18.08 | $20.28 |
| Revenue Next Year | $19.65 | N/A |
| P/E Ratio | ★ N/A | $23.69 |
| Revenue Growth | N/A | ★ 63.92 |
| 52 Week Low | $131.81 | $48.47 |
| 52 Week High | $256.36 | $68.24 |
| Indicator | NTRA | EQT |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 41.53 |
| Support Level | $187.27 | $56.26 |
| Resistance Level | $204.34 | $57.62 |
| Average True Range (ATR) | 10.36 | 1.36 |
| MACD | -1.12 | -0.13 |
| Stochastic Oscillator | 28.02 | 27.60 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.